Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: An overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol

International Journal of Geriatric Psychiatry

Volumn 27, Issue 2, 2012, Pages 205-214

  Gaussoin, Sarah A ^a   Espeland, Mark A ^a   Absher, John ^c   Howard, Barbara V ^b   Jones, Beverley M ^a   Rapp, Stephen R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c Absher Neurology   (United States)

Author keywords

attrition; cognitive impairment; dementia; missing data; women's health

Indexed keywords

AGE; AGED; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DEMENTIA; DIABETES MELLITUS; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; POSTMENOPAUSE; QUESTIONNAIRE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SMOKING; SOCIOECONOMICS; SUPPLEMENTAL PROXY BASED PROTOCOL; TELEMONITORING; TWO STAGED CLINIC BASED STANDARDIZED PROTOCOL;

AGED; COGNITION; COGNITION DISORDERS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROXY; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; WOMEN'S HEALTH;

EID: 84855454239     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2714     Document Type: Review

References (33)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association: Washington, D.C.
2. Anderson GL, Limacher M, Assaf AR, et al,. 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291: 1701-1712. (Pubitemid 38489892)
3. Bernstein AB, Remsburg RE,. 2007. Estimated prevalence of people with cognitive impairment: results from nationally representative community and institutional surveys. Gerontologist 47: 350-354. (Pubitemid 47308974)
4. Carr DB, Gran S, Baty J, Morris JC,. 2000. The value of informant versus individual's complaints of memory impairment in elderly dementia. Neurology 55: 1724-1726.
5. Cooper C, Tandy AR, Balamurali TB, Livingston G,. 2010. A systematic review and meta analysis of ethnic differences in use of dementia treatment, care, and research. Am J Geriatr Psychiatry 18 (3): 193-203.
6. Crooks VC, Clark L, Petitti DB, Chui H, Chiu V,. 2005. Validation of multi-stage telephone based identification of cognitive impairment and dementia. BMC Neurol 5 (1): 5-8.
7. Desmond DW, Bagiealla E, Moroney JT, Stern Y,. 1998. The effect of patient attrition on estimates of the frequency of dementia following stroke. Arch Neurol 55: 390-394. (Pubitemid 28146204)
8. Ellenberg SS,. 2004 Analytical, practical and regulatory issues in prevention studies. Stat Med 23 (2): 297-303. (Pubitemid 38100642)
9. Ellis RJ, Jan K, Kawas C, et al,. 1998. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol 55 (3): 360-365. (Pubitemid 28146201)
10. Espeland MA, Rapp SR, Shumaker SA, et al,. 2004. Conjugated equine estrogens on global cognitive function in postmenopausal women. JAMA 291: 2959-2969.
11. Ferrucci L, Guralnik JM, Studenski S, et al,. 2004. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 52 (4): 625-634. (Pubitemid 38480644)
12. Gallo JJ, Breitner JC,. 1995. Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med 25 (6): 1211-1219.
13. Gao S, Hui SL,. 2000. Estimating the incidence of dementia from two-phase sampling with non-ignorable missing data. Statist Med 19: 1545-1554. (Pubitemid 30346245)
14. Harel O, Hofer SM, Hoffman L, Pedersen NL, Johansson B,. 2007. Population inference with mortality and attrition in longitudinal studies on aging: a two-stage multiple imputation method. Exp Aging Res 33: 187-203. (Pubitemid 46385589)
15. Hayden KM, Khachaturian AS, Tschanz JT, et al,. 2003. Characteristics of a two-stage screen for incident dementia. J Clin Epidemiol 56 (11): 1038-1045. (Pubitemid 37386330)
16. Izmirlian G, Brock D, White L,. 2000. Estimating incidence of dementia subtypes: assessing the impact or missed cases. Statist Med 19: 1577-1591. (Pubitemid 30346248)
17. Jorm AF, Jacomb PA,. 1989. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity, and some norms. Psychol Med 19: 1015-1022. (Pubitemid 20012268)
18. Kawas C, Segal J, Stewart WF, Corrada M, Thal LJ,. 1994. A validation study of the dementia questionnaire. Arch Neurol 51 (9): 901-906. (Pubitemid 24286045)
19. Khachaturian AS, Gallo JJ, Breitner JC,. 2000. Performance characteristics of a two-stage dementia screen in a population sample. J Clin Epidemiol 53 (5): 531-540. (Pubitemid 30254351)
20. Lebowitz BD,. 2004. Clinical trials in late life: new science in old paradigms. Gerontologist 44 (4): 452-458. (Pubitemid 39128879)
21. Morris JC, Heyman A, Mohs RC, et al,. 1989. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39: 1159-1165. (Pubitemid 19239715)
22. Prentice RL, Anderson G, Cummings S, et al,. 1998. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 19: 61-109. (Pubitemid 28085557)
23. Rocca WA, Bower JH, Ahlskog JE, et al,. 2007. Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol 64: 1458-1464. (Pubitemid 47572669)
24. Rossouw JE, Anderson GL, Prentice RL, et al,. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333. (Pubitemid 34761611)
25. Shumaker SA, Reboussin BA, Espeland MA, et al,. 1998. The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 19: 604-621. (Pubitemid 29057725)
26. Shumaker S, Legault C, Rapp S, et al,. 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289: 2651-2662. (Pubitemid 37430136)
27. Shumaker SA, Legault C, Kuller L, et al,. 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 291: 2947-2958. (Pubitemid 38802684)
28. Silverman JM, Breitner JC, Mohs RC, Davis KL,. 1986. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry 143: 1279-1282. (Pubitemid 16008715)
29. Song X, Davidian M, Tsiatis AA,. 2002a. An estimator for the proportional hazards model with multiple longitudinal covariates measured with error. Biostatistics 3: 511-528. (Pubitemid 35431227)
30. Song X, Davidian M, Tsiatis AA,. 2002b. A semiparametric likelihood approach to joint modeling of longitudinal and time-to-event data. Biometrics 58: 742-753. (Pubitemid 36133752)
31. Teng EL, Chui HC,. 1987. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48: 314-318. (Pubitemid 17138128)
32. Tsiatis AA, Davidian M,. 2001. A semiparametric estimator for the proportional hazards model with longitudinal covariates measured with error. Biometrika 88: 447-458. (Pubitemid 33770998)
33. Tsiatis AA, Davidian M,. 2004. Joint modeling of longitudinal and time-to-event data: an overview. Stat Sin 14: 809-834. (Pubitemid 39499214)